3-day Virtual Seminar

Generative AI in Pharma & Biotech

Overview

This webinar demystifies Generative AI for Pharma and Biotech executives by breaking it down into practical use cases, real-world implementations, governance considerations, and ROI models. The session blends strategic insights with hands-on examples, demonstrating how GenAI can be embedded across the R&D, Medical Affairs, Commercial, Safety, and Regulatory value chain. Attendees will walk away with a clear roadmap on where to begin, how to scale, and how to assess value responsibly.

Why you should Attend

• To understand how GenAI will redefine R&D productivity, regulatory compliance, safety, MedAff and commercial strategy
• To learn what is truly possible today (beyond the hype) and where investments create immediate impact
• To gain clarity on AI governance, risk mitigation, and compliance frameworks specifically suited for Pharma/ Biotech environments
• To translate GenAI capabilities into practical, defensible business cases for your function or therapy area
• To understand how competitors and global innovators are already applying GenAI

"Your competitors are already leveraging GenAI to accelerate molecule discovery, automate regulatory workflows, and enhance HCP engagement. The risk today is not that GenAI will replace your teams but that your teams will fall behind organizations that learn to use it faster."

Areas Covered in the Session

• Industry Context & GenAI Landscape
  
• High Impact use cases by function
  
• GenAI Architectures for Pharma
  
• Risks, Compliance & Responsible AI
  

Who Will Benefit

• All